GH Research (GHRS) Current Leases (2023 - 2025)

GH Research (GHRS) recorded quarterly Current Leases of $365000.0 in Q4 2025, up 43.14% quarter-over-quarter from $255000.0 in Q4 2024, and up 43.14% on a YoY basis from $255000.0 in Q4 2024.

GH Research (GHRS) Current Leases (2023 - 2025) Analysis & Trends

GH Research's Current Leases history runs 3 years deep, the most recent figure standing at $365000.0 for Q4 2025.

  • In Q4 2025, Current Leases rose 43.14% year-over-year to $365000.0; the TTM figure through Dec 2025 stood at $365000.0 (up 43.14% YoY), while the FY2025 annual figure was $365000.0, up 43.14% from the prior year.
  • Current Leases was $365000.0 for Q4 2025 at GH Research, up from $255000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $365000.0 in Q4 2025 to a low of $255000.0 in Q4 2024.
  • Historically, Current Leases has averaged $321000.0 across 3 years, with a median of $343000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Current Leases decreased 25.66% in 2024, then jumped 43.14% in 2025.
  • A 3-year view of Current Leases shows it stood at $343000.0 in 2023, then fell by 25.66% to $255000.0 in 2024, then surged by 43.14% to $365000.0 in 2025.
  • The last three Current Leases figures came in at $365000.0 (Q4 2025), $255000.0 (Q4 2024), and $343000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 83,991.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 7.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 GH Research 9.73 Bn 9.63 Bn - 365,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 365,000.00
Dec 31, 2024 255,000.00
Dec 31, 2023 343,000.00